Skip to Content

P-6100

Main Content

Blood Advances | 2025

Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.

Locke FL, Siddiqi T, Jacobson CA, Nikiforow S, Ahmed S, Miklos DB, Lin Y, Lunning MA, Hill BT, Ghobadi A, Hu ZH, Hemmer MT, Zoratti MJ, Vunnum S, Tsang J, Spooner C, Smith H, Fu C, Patel AR, Miao H, Shahani SA, Mirjah DL, Xu H, Pasquini MC

PubMed
PMID: 39883946

Abstract
Related Articles

CIBMTR Study #: SC17-07f